[HTML][HTML] Preclinical cancer models and biomarkers for drug development: new technologies and emerging tools

M Dhandapani, A Goldman - Journal of molecular biomarkers & …, 2017 - ncbi.nlm.nih.gov
Background and purpose Predicting the efficacy of anticancer therapy is the holy grail of
drug development and treatment selection in the clinic. To achieve this goal, scientists …

Patient-derived cancer models: Valuable platforms for anticancer drug testing

S Genta, B Coburn, DW Cescon, A Spreafico - Frontiers in Oncology, 2022 - frontiersin.org
Molecularly targeted treatments and immunotherapy are cornerstones in oncology, with
demonstrated efficacy across different tumor types. Nevertheless, the overwhelming majority …

Preclinical models for precision oncology

M Ibarrola-Villava, A Cervantes, A Bardelli - Biochimica et Biophysica Acta …, 2018 - Elsevier
Precision medicine approaches have revolutionized oncology. Personalized treatments
require not only identification of the driving molecular alterations, but also development of …

Personalized cancer models for target discovery and precision medicine

C Grandori, CJ Kemp - Trends in cancer, 2018 - cell.com
Although cancer research is progressing at an exponential rate, translating this knowledge
to develop better cancer drugs and more effectively match drugs to patients is lagging …

Harnessing the predictive power of preclinical models for oncology drug development

A Honkala, SV Malhotra, S Kummar… - Nature reviews Drug …, 2022 - nature.com
Recent progress in understanding the molecular basis of cellular processes, identification of
promising therapeutic targets and evolution of the regulatory landscape makes this an …

Navigating the challenge of tumor heterogeneity in cancer therapy

C Fedele, RW Tothill, GA McArthur - Cancer discovery, 2014 - AACR
The future of cancer treatment lies in personalized strategies designed to specifically target
tumorigenic cell populations present in an individual. Although recent advances in directed …

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi… - Cancer discovery, 2017 - AACR
Precision medicine is an approach that takes into account the influence of individuals'
genes, environment, and lifestyle exposures to tailor interventions. Here, we describe the …

From cell lines to living biosensors: new opportunities to prioritize cancer dependencies using ex vivo tumor cultures

YY Tseng, JS Boehm - Current Opinion in Genetics & Development, 2019 - Elsevier
Precision cancer medicine is based on the ability to predict the dependencies of a given
tumor from its molecular makeup. These dependencies can be exploited with targeted …

Role of patient-derived models of cancer in translational oncology

KF Idrisova, HU Simon, MO Gomzikova - Cancers, 2022 - mdpi.com
Simple Summary It was found that long-established tumor-derived cell lines do not
adequately reproduce drug sensitivity and behavior of a real human cancers. Therefore …

[HTML][HTML] Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation

N Batis, JM Brooks, K Payne, N Sharma… - Advanced Drug Delivery …, 2021 - Elsevier
Predictive tools, utilising biomarkers, aim to objectively assess the potential response to a
particular clinical intervention in order to direct treatment. Conventional cancer therapy …